Skip to main content

Table 2 Expression of TRIB3 in different types of ovarian tissue

From: Down-regulation of TRIB3 inhibits the progression of ovarian cancer via MEK/ERK signaling pathway

Group Cases Low High Positive rate (%) High Positive rate (%)
+ ++ +++
Malignant 94 23 19 23 29 75.5a,b 60.6c,d
Borderline 16 8 4 2 2 50e,f 25 g,h
Benign 14 9 4 1 0 35.7 7.1
Normal 13 10 3 0 0 23.1 0
  1. aMalignant vs. benign (**P = 0.004)
  2. bMalignant vs. normal (***P < 0.001)
  3. cMalignant vs. benign (***P = 0.001)
  4. dMalignant vs. normal (***P < 0.001)
  5. eBorderline vs. benign (P = 0.431)
  6. fBorderline vs. normal (P = 0.249)
  7. gBorderline vs. benign (P = 0.336)
  8. hBorderline vs. normal (P = 0.107)